Position in MDGL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$138,501,263
-$16,229,386 QoQ
Shares Held
264,583
-0.4% QoQ
Ownership
1.15%
of shares outstanding
% of Portfolio
4.55%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in MDGL Over Time
Shares Held
Position Value (USD)
Derivatives in MDGL
reported options exposure · as of Sep 30, 2025CallValue
$59,625,800
CallShares
130,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026ARMISTICE CAPITAL, LLC holds $1,388,824,976 across 55 Biotechnology names. MDGL ranks #3 (10.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TVTX |
Travere Therapeutics, Inc.
|
4,897,417 | $145,502,259 | |
| 2 | PTCT |
Ptc Therapeutics, Inc.
|
2,074,449 | $141,332,210 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
This page
|
264,583 | $138,501,263 | |
| 4 | AGIO |
Agios Pharmaceuticals, Inc.
|
2,716,000 | $91,882,280 | |
| 5 | IMVT |
Immunovant, Inc.
|
3,564,916 | $88,552,513 | |
| 6 | INCY |
Incyte Corp
|
656,817 | $61,819,616 | |
| 7 | DYN |
Dyne Therapeutics, Inc.
|
3,175,110 | $57,564,744 | |
| 8 | CYTK |
Cytokinetics Inc
|
764,538 | $50,390,699 |
All Filings in MDGL
Export CSV
32 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $138,501,263 | 264,583 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $154,730,649 | 265,705 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $59,625,800 | 130,000 | Call | Sole | 2025-11-17 | |
| 2025-09-30 | $55,030,944 | 119,982 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $37,527,360 | 124,000 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $51,448,800 | 170,000 | Call | Sole | 2025-08-14 | |
| 2025-03-31 | $99,369,000 | 300,000 | Call | Sole | 2025-05-15 | |
| 2025-03-31 | $45,008,526 | 135,883 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $30,857,000 | 100,000 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $10,592,961 | 49,915 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $42,024,000 | 150,000 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $44,862,720 | 168,000 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $64,786,400 | 280,000 | Call | Sole | 2024-02-13 | |
| 2023-12-31 | $11,569,000 | 50,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $15,772,320 | 108,000 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | $23,366,400 | 160,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | $73,920,000 | 320,000 | Put | Sole | 2023-08-14 | |
| 2023-06-30 | $31,416,000 | 136,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $30,282,500 | 125,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | $66,863,760 | 276,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $60,372,000 | 208,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $80,327,640 | 1,236,000 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $78,738,000 | 1,100,000 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $95,961,360 | 978,000 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $95,247,760 | 1,124,000 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $82,662,440 | 1,036,000 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $57,666,720 | 592,000 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $40,939,500 | 350,000 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $35,129,720 | 316,000 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $33,006,940 | 278,000 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $28,086,000 | 248,000 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $14,420,160 | 216,000 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||